Abstract
The purpose of this study was to examine decision-making among women considering antidepressant medication use in pregnancy. Decisional conflict was assessed using the Decisional Conflict Scale (DCS) among pregnant women considering antidepressant medication treatment (N = 40). Overall DCS and subscale scores were compared between women who were antidepressant users and non-users. Semi-structured interviews (N = 10) explored barriers and facilitators of decision-making. Twenty-one women (52 %) had moderate or high decisional conflict (DCS ≥ 25). Overall DCS scores did not differ between groups, but antidepressant use was associated with feeling more adequately informed (subscale mean 17.5, SD 17.9 vs. 42.1, SD 23.8, p = 0.001) and clear about values (subscale mean 16.7, SD 15.1 vs. 29.8, SD 24.0, p = 0.043). Barriers to decision-making were (1) difficulty weighing maternal versus infant health, (2) lack of high quality information, (3) negative external influences, and (4) emotional reactions to decision-making. Facilitators were (1) interpersonal supports, (2) accessible subspecialty care, and (3) severe depressive symptoms. Many pregnant women facing decisions regarding antidepressant medication use experience decisional conflict. Interventions that provide accurate information, assistance with weighing risks and benefits of treatment, management of problematic external influences, and emotional support may reduce decisional conflict and facilitate the decision-making process.
Similar content being viewed by others
References
Battle CL, Salisbury AL, Schofield CA, Ortiz-Hernandez S (2013) Perinatal antidepressant use: understanding women’s preferences and concerns. J Psychiatr Pract 19(6):443–453
Beck CT (1998) The effects of postpartum depression on child development: a meta-analysis. Arch Psychiatr Nurs 12(1):12–20
Bonari L, Koren G, Einarson TR, Jasper JD, Taddio A, Einarson A (2005) Use of antidepressants by pregnant women: evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making. Arch Womens Ment Health 8(4):214–220
Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3:77–101
Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA (2006) Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354(6):579–587
Dennis CL, Coghlan M, Vigod S (2013) Can we identify mothers at-risk for postpartum anxiety in the immediate postpartum period using the State-Trait Anxiety Inventory? J Affect Disord. doi:10.1016/j.jad.2013.05.049
Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, Fawcett J (2010) Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 303(1):47–53. doi:10.1001/jama.2009.1943
Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T (2005) Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 106(5 Pt 1):1071–1083
Gibson J, McKenzie-McHarg K, Shakespeare J, Price J, Gray R (2009) A systematic review of studies validating the Edinburgh Postnatal Depression Scale in antepartum and postpartum women. Acta Psychiatr Scand 119(5):350–364
Grigoriadis S, VonderPorten EH, Mamisashvili L, Eady A, Tomlinson G, Dennis CL, Ross LE (2013a) The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. J Clin Psychiatry 74(4):e309–e320
Grigoriadis S, VonderPorten EH, Mamisashvili L, Roerecke M, Rehm J, Dennis CL, Ross LE (2013b) Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence. J Clin Psychiatry 74(4):e293–e308
Grigoriadis S, VonderPorten EH, Mamisashvili L, Tomlinson G, Dennis CL, Koren G, Ross LE (2013c) The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry 74(4):e321–e341
Guest G, Bunce A, Johnson L (2006) How many interviews are enough? An experiment with data saturation and variability. Field Methods 18(1):59–82
Hammen C, Brennan PA (2003) Severity, chronicity, and timing of maternal depression and risk for adolescent offspring diagnoses in a community sample. Arch Gen Psychiatry 60(3):253–258
Janis I (1977) Decision making. The Free Press, New York
Kennedy SH, Lam RW, Parikh SV, Patten SB, Ravindran AV (2009) Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction. J Affect Disord 117(Suppl 1):S1–S2
Marcus SM, Flynn HA (2008) Depression, antidepressant medication, and functioning outcomes among pregnant women. Int J Gynaecol Obstet 100(3):248–251
Martins C, Gaffan EA (2000) Effects of early maternal depression on patterns of infant-mother attachment: a meta-analytic investigation. J Child Psychol Psychiatry 41(6):737–746
Murray L (1992) The impact of postnatal depression on infant development. J Child Psychol Psychiatry 33(3):543–561
Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, Koren G (2002) Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 159(11):1889–1895
O’Connor AM (1995) Validation of a decisional conflict scale. Med Decis Making 15(1):25–30
O’Connor A (1997) Decisional conflict. In: McFarland G, McFarlane E (eds) Nursing diagnosis and intervention, 3rd edn. The CV Mosby Co., St. Louis, pp 486–496
O’Connor A (2006) Ottawa Decision Support Framework to address decisional conflict. http://www.ohri.ca/decisionaid. Accessed 3 April 2014)
O’Connor A, Jacobsen M (2007) Decisional Conflict: supporting people experiencing uncertainty about options affecting their health. Ottawa Health Decision Centre, Ottawa
O’Hara MW, Swain AM (1996) Rates and risk of postpartum depression—a meta-analysis. Int Rev Psychiatry 8(1):37–54
Orr ST, Miller CA (1995) Maternal depressive symptoms and the risk of poor pregnancy outcome. Review of the literature and preliminary findings. Epidemiol Rev 17(1):165–171
Patel SR, Wisner KL (2011) Decision making for depression treatment during pregnancy and the postpartum period. Depress Anxiety 28(7):589–595. doi:10.1002/da.20844
Ross LE, Grigoriadis S, Mamisashvili L, Vonderporten EH, Roerecke M, Rehm J, Cheung A (2013) Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry 70(4):436–443
Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Fava M (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163(11):1905–1917
Sinclair D, Murray L (1998) Effects of postnatal depression on children’s adjustment to school. Teacher’s reports. Br J Psychiatry 172:58–63
Sjöberg L (1983) To smoke or not to smoke: conflict or lack of differentiation? In: Humphreys P, Sevenson O, Vari A (eds) Analysing and aiding decision processes. Elsevier, New York
Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, Thomson R (2011) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev(10), CD001431
Steer RA, Scholl TO, Hediger ML, Fischer RL (1992) Self-reported depression and negative pregnancy outcomes. J Clin Epidemiol 45(10):1093–1099
Vlemmix F, Warendorf JK, Rosman AN, Kok M, Mol BW, Morris JM, Nassar N (2013) Decision aids to improve informed decision-making in pregnancy care: a systematic review. BJOG 120(3):257–266
Volk R, Llewellyn-Thomas H (2012) The 2012 IPDAS Background Document: bibAn Introduction. In: Volk R, Llewellyn-Thomas H (Eds.), 2012 Update of the International Patient Decision Aid Standards (IPDAS) Collaboration’s Background Document. http://www.ipdas.ohri.ca/resources.html. Accessed 4 April 2014
Weinberg MK, Tronick EZ (1998) The impact of maternal psychiatric illness on infant development. J Clin Psychiatry 59(Suppl 2):53–61
Wen SW, Yang Q, Garner P, Fraser W, Olatunbosun O, Nimrod C, Walker M (2006) Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol 194(4):961–966
Wills CE, Holmes-Rovner M (2003) Preliminary validation of the satisfaction with decision scale with depressed primary care patients. Health Expect 6(2):149–159
Zuckerman B, Amaro H, Bauchner H, Cabral H (1989) Depressive symptoms during pregnancy: relationship to poor health behaviors. Am J Obstet Gynecol 160(5 Pt 1):1107–1111
Zuckerman B, Bauchner H, Parker S, Cabral H (1990) Maternal depressive symptoms during pregnancy, and newborn irritability. J Dev Behav Pediatr 11(4):190–194
Acknowledgments
The study was conducted at the Women’s College Research Institute, Women’s College Hospital, fully affiliated with the University of Toronto, in Toronto, Ontario, Canada. We would like to acknowledge Ms. Talia Leszcz and Ms. Sarah Somerton for their important work in the preparation of research ethics boards submissions, data collection, and overall study management for this research project. Ms. Leszcz and Ms. Somerton were employed as research assistants through the Women’s College Research Institute at Women’s College Hospital in Toronto, Ontario. Funding for the research was provided by an operating grant from the Alternate Funding Program Physician Innovation Fund of the Ontario Ministry of Health and Long Term Care (MOHLTC). The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by the Ontario MOHLTC is intended or should be inferred.
Integrity of research and reporting
This study was approved by the Research Ethics Board at Women’s College Hospital in Toronto, Ontario (REB# 2011-0011-B, approved May 16, 2011) and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All persons gave their informed consent prior to inclusion in the study.
Conflict of interest
The authors of this study report no conflict of interest. Within the past 3 years, Dr. Vigod and Dr. Grigoriadis received a one-time consulting fee from Multi-Dimensional Health Care (MDH) consulting for the development of continuing health-care activities related to perinatal mental health, Dr. Vigod and Dr. Stewart received compensation as UpTodate co-authors of Infants and Antenatal Exposure to SSRIs and SNRIs During Pregnancy, Dr. Stewart is on the Scientific Advisory Board of Cymbalta Pregnancy Registry, Eli Lilly, and Drs. Walton, Ross, and Dennis have no relevant financial disclosures.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 18 kb)
Rights and permissions
About this article
Cite this article
Walton, G.D., Ross, L.E., Stewart, D.E. et al. Decisional conflict among women considering antidepressant medication use in pregnancy. Arch Womens Ment Health 17, 493–501 (2014). https://doi.org/10.1007/s00737-014-0448-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00737-014-0448-1